Core Points - Queen's Road Capital Investment Ltd. has received approval from its Board of Directors to continue its normal course issuer bid (NCIB) for an additional 12 months, known as the 2025 NCIB [1] - The company plans to repurchase up to 1,760,000 common shares, which is approximately 3.45% of its total issued and outstanding shares as of November 13, 2025 [2] - The repurchased shares will be cancelled and returned to treasury, with purchases made through the Toronto Stock Exchange (TSX) and alternative trading systems in Canada [2] Summary by Sections NCIB Details - The 2025 NCIB will commence on November 24, 2025, and will end on November 23, 2026, unless the maximum number of shares is purchased earlier or the NCIB is terminated [3] - The company will determine the timing, amount, and price of purchases based on market conditions, adhering to TSX and regulatory requirements [3] Purchase Limitations - Under TSX rules, a maximum of 3,089 common shares can be purchased on any single trading day, which is 25% of the average daily trading volume over the past six months [4] Previous NCIB Performance - The 2025 NCIB follows the 2024 NCIB, under which the company purchased 257,756 common shares for approximately C$1.8 million at an average price of C$7.05 per share [5] - The 2024 NCIB authorized the purchase of 1,760,000 common shares, with adjustments made for share consolidation effective January 15, 2025 [5] Company Overview - Queen's Road Capital Investment Ltd. is a dividend-paying investment company focused on the global resource sector, investing in both privately held and publicly traded companies [6] - The company aims for long-term capital appreciation, particularly in convertible debt securities and resource projects in politically stable regions [6]